326
Participants
Start Date
January 6, 2021
Primary Completion Date
February 13, 2023
Study Completion Date
March 31, 2023
Trilaciclib
Trilaciclib diluted in dextrose 5% in water or normal saline (sodium chloride solution 0.9%) administered by IV infusion over approximately 30 (±10) minutes no more than 4 hours prior to each Day 1 chemotherapy administration. Second dose of trilaciclib was administered on Day 2.
Placebo
Dextrose 5% in water or normal saline (sodium chloride solution 0.9%) administered by IV infusion over 30 (±10) minutes no more than 4 hours prior to each Day 1 chemotherapy administration. Second dose of placebo was administered on Day 2.
Orszagos Onkologiai Intezet, Budapest
SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz, Nyíregyháza
Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula
Bacs-Kiskun Megyei Oktatokorhaz, Kecskemét
"Limited Liability Company Medical Center named by Academician Yuriy Prokopovich Spizhenko", Kapitanivka
ASL Regionale Piemonte - Ospedale Santo Spirito Casale Monferrato (Ospedale di Casale Monferrato), Casale Monferrato
Gettysburg Cancer Center, Gettysburg
CI Cherkasy Regional Oncological Dispensary of CRC, Cherkasy
Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
Inova Schar Cancer Institute, Fairfax
Onc and Hem Assoc of SW VA, Roanoke
Hospital Universitari Arnau de Vilanova, Lleida
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Cremona
Hospital Universitario Lucus Augsti, Lugo
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario HM Madrid Sanchinarro, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Madrid
Northside Hospital - Georgia Cancer Specialists, Atlanta
Florida Cancer Specialists - Panhandle, Tallahassee
Mid-Florida Hematology & Oncology Centers, P.A., Orange City
Florida Cancer Specialists, St. Petersburg
Florida Cancer Specialists (South Region), Fort Myers
Florida Cancer Specialists NORTH, Fort Myers
Tennessee Oncology, Nashville
University Hospital of Sumy State University, Sumy
Hospital Universitario Virgen Macarena, Seville
Hospital Universitario Virgen del Rocio, Seville
Communal Enterprise Volyn Regional Medical Center of Oncology of Volyn Regional Council, Lutsk
Hospital Clinico Universitario de Valencia, Valencia
MI Regional Clinical Oncologycal Dispensary, Dnipro
Dnipropetrovsk City Multispecialty Clinical Hospital #4, Dnipro
Hospital Universitario Miguel Servet, Zaragoza
CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih
Azienda Ospedaliera Universitaria Careggi, Florence
Mayo Clinic - Rochester, Rochester
Illinois Cancer Specialists, Arlington Heights
CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC, Kharkiv
Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv NMU, Kharkiv
Communal Institution Odesa Regional Clinical Hospital; Department of Surgery, Odesa
"Medical center Oncolife LLC", Zaporizhzhia
University of Oklahoma Health Sciences Center, Oklahoma City
UT Southwestern Medical Center, Dallas
Millennium Oncology, Kingswood
AZ Oncology Associates - HOPE, Tucson
Comp. Cancer Centers of Nevada, Las Vegas
Keck Medical Center of USC Pasadena, Los Angeles
Beverly Hills Cancer Center, Beverly Hills
The Oncology Institute of Hope & Innovation\ Innovative Clinical Research Institute, Whittier
Oregon Health & Science University, Portland
Zhongshan Hospital Fudan University, Shanghai
Boston Medical Center, Boston
University of Massachusetts Memorial Medical Center, Worcester
Henan Cancer Hospital, Zijingshan
Wuhan Union Hospital, Wuhan
Jilin Provincial Tumor Hospital, Changchun
The First Affiliated Hospital of Zhejiang University, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
The Affiliated Tumor Hospital of Harbin Medical University, Heilongjiang
Jinan Central hospital, Shandong
Xuzhou Central hospital, Xuzhou
First Affiliated Hospital of Zhengzhou University, Zhengzhou
Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus, Kropyvnytskyi
Medical Center Asklepion LLC, Kyiv
Medical Center of Limited Liability Company Medical Center Concilium Medical, Kyiv
CNE CCCH of Uzh CC Oncological Center, Ther Dept, SHEI UNU, Uzhhorod
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Rome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Szpitale Pomorskie spółka z ograniczoną odpowiedzialnością, Gdynia
Szpital Specjalistyczny im. L.Rydygiera w Krakowie, Krakow
Mrukmed Lekarz Beata Madej Mruk i Partner Spółka Partnerska Oddział nr 1 w Rzeszowie, Rzeszów
Centrum Medyczne Pratia Poznan, Skórzewo
Centrum Zdrowia MDM, Warsaw
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona
Barts Hospital, London
Royal Free Hospital, London
The Christie, Manchester
Velindre Cancer Centre, Cardiff
Lead Sponsor
G1 Therapeutics, Inc.
INDUSTRY